Abametapir 0.74% (Xeglyze) for the Treatment of Head Lice.
Where this comes from
- Record sourced from PubMed, PMID 35839355.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Abametapir 0.74% (Xeglyze) is a topical ovicidal pediculicide labeled for the treatment of head lice infestation in patients six months and older.1,2.
Medical subject headings
- Dermatologic Agents
- Insecticides
- Lice Infestations
- Pediculus